Literature DB >> 28791497

Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.

Ho Won Kang1,2, Sung Pil Seo1,2, Won Tae Kim1,2, Seok Joong Yun1,2, Sang-Cheol Lee1,2, Wun-Jae Kim1,2, Eu Chang Hwang3, Seok Ho Kang4, Sung-Hoo Hong5, Jinsoo Chung6, Tae Gyun Kwon7, Hyeon Hoe Kim8, Cheol Kwak8, Seok-Soo Byun9, Yong-June Kim10,11.   

Abstract

BACKGROUND: The prognostic implications of preoperative serum total cholesterol (TC) level in patients with renal cell carcinoma (RCC) remain poorly understood. We investigated the prognostic role of preoperative serum TC in patients with surgically treated RCC from a large, multi-institutional Korean collaboration. PATIENTS AND METHODS: A database of 3064 patients with RCC who underwent radical or partial nephrectomy between 1999 and 2011 at eight academic centers was analyzed. Preoperative serum TC levels were measured in fasting blood samples.
RESULTS: Low preoperative serum TC level was associated with aggressive tumor characteristics, including large tumor size, advanced stage, high nuclear grade, lymph node involvement, and sarcomatous differentiation (all P < 0.001). Low TC level was associated with poor recurrence-free or cancer-specific survival (CSS) in the entire cohort, whereas the significance of the association changed after stratification by disease stage and histologic subtype. Multivariate Cox regression analysis showed that preoperative TC, as a continuous or categorical variable, was an independent predictor of CSS.
CONCLUSIONS: Preoperative low serum TC level was associated with aggressive tumor characteristics and poor CSS in patients with surgically treated RCC. Preoperative TC may provide additional guidance regarding the choice of therapeutic strategies to improve prognosis.

Entities:  

Keywords:  Cholesterol; Nephrectomy; Prognosis; Renal cell carcinoma; Survival

Mesh:

Substances:

Year:  2017        PMID: 28791497     DOI: 10.1007/s10147-017-1172-4

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  30 in total

1.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.

Authors:  John R Srigley; Brett Delahunt; John N Eble; Lars Egevad; Jonathan I Epstein; David Grignon; Ondrej Hes; Holger Moch; Rodolfo Montironi; Satish K Tickoo; Ming Zhou; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

Review 2.  Evidence-based clinical practice guideline for renal cell carcinoma: the Japanese Urological Association 2011 update.

Authors:  Tomoaki Fujioka; Wataru Obara
Journal:  Int J Urol       Date:  2012-06       Impact factor: 3.369

Review 3.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 4.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

5.  Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.

Authors:  Alexander S Parker; Christine M Lohse; John C Cheville; David D Thiel; Bradley C Leibovich; Michael L Blute
Journal:  Urology       Date:  2006-10       Impact factor: 2.649

6.  Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma.

Authors:  Yoshio Ohno; Jun Nakashima; Yoshihiro Nakagami; Tatsuo Gondo; Makoto Ohori; Tadashi Hatano; Masaaki Tachibana
Journal:  Urology       Date:  2013-10-19       Impact factor: 2.649

7.  Statins as anti-cancer therapy; Can we translate preclinical and epidemiologic data into clinical benefit?

Authors:  Young Kwang Chae; Muhammad Yousaf; Mary-Kate Malecek; Benedito Carneiro; Sunandana Chandra; Jason Kaplan; Aparna Kalyan; Antonella Sassano; Leonidas C Platanias; Francis Giles
Journal:  Discov Med       Date:  2015-12       Impact factor: 2.970

8.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

9.  Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study.

Authors:  Chunfang Zhang; Luping Yu; Tao Xu; Yichang Hao; Xiaowei Zhang; Zhenhua Liu; Yunbei Xiao; Xiaofeng Wang; Qiang Zeng
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

10.  Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection.

Authors:  Hye Won Lee; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Han Yong Choi; Hyun Moo Lee
Journal:  J Korean Med Sci       Date:  2015-08-13       Impact factor: 2.153

View more
  7 in total

1.  The prognostic significance of preexisting diabetes in patients with surgically treated renal cell carcinoma: the ongoing debate.

Authors:  Ho Won Kang; Yong-June Kim
Journal:  Ann Transl Med       Date:  2019-12

2.  The Controlling Nutritional Status CONUT Score in Patients With Advanced Bladder Cancer After Radical Cystectomy.

Authors:  Yuki Nemoto; Tsunenori Kondo; Hiroki Ishihara; Toshio Takagi; Hironori Fukuda; Kazuhiko Yoshida; Junpei Iizuka; Hideki Ishida; Kazunari Tanabe
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

3.  HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma.

Authors:  Jiajun Huang; Xiaoyu Zhao; Xiang Li; Jiwei Peng; Weihao Yang; Shengli Mi
Journal:  PLoS Biol       Date:  2021-04-27       Impact factor: 8.029

4.  Diagnostic and prognostic value of ABC transporter family member ABCG1 gene in clear cell renal cell carcinoma.

Authors:  Fucheng Meng; Yafei Xiao; Longxiang Xie; Qiao Liu; Keli Qian
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

5.  Prognostic value of the controlling nutritional status score in patients with myelodysplastic syndromes.

Authors:  Qiuni Chen; Kankan Chen; Sumei Wang; Lijuan Zhang; Yuye Shi; Shandong Tao; Zhengmei He; Chunling Wang; Liang Yu
Journal:  Front Nutr       Date:  2022-07-27

6.  Added Value of Systemic Inflammation Markers in Predicting Clinical Stage T1 Renal Cell Carcinoma Pathologically Upstaged to T3a.

Authors:  Hailang Liu; Zhixian Wang; Ejun Peng; Zhiqiang Chen; Kun Tang; Ding Xia
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

7.  Validation of the preoperative controlling nutritional status score as an independent predictor in a large Chinese cohort of patients with upper tract urothelial carcinoma.

Authors:  Hang Xu; Ping Tan; Xi Jin; Jianzhong Ai; Tianhai Lin; Haoran Lei; Lu Yang; Qiang Wei
Journal:  Cancer Med       Date:  2018-11-28       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.